Different expression of S100A8 in malignant and benign gallbladder diseases.
about
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics.The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinomaEvaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing CholangitisBile proteome in health and disease.Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
P2860
Different expression of S100A8 in malignant and benign gallbladder diseases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Different expression of S100A8 in malignant and benign gallbladder diseases.
@en
Different expression of S100A8 in malignant and benign gallbladder diseases.
@nl
type
label
Different expression of S100A8 in malignant and benign gallbladder diseases.
@en
Different expression of S100A8 in malignant and benign gallbladder diseases.
@nl
prefLabel
Different expression of S100A8 in malignant and benign gallbladder diseases.
@en
Different expression of S100A8 in malignant and benign gallbladder diseases.
@nl
P2093
P2860
P1476
Different expression of S100A8 in malignant and benign gallbladder diseases.
@en
P2093
Hui-Zhen Zhang
Kai-Xing Ai
Xin-Yu Huang
P2860
P2888
P304
P356
10.1007/S10620-012-2307-0
P577
2012-07-18T00:00:00Z